Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease

Adenosine A₁-A_2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease

Front Neurosci. 2017 Nov 22:11:652. doi: 10.3389/fnins.2017.00652. eCollection 2017.

Víctor Fernández-Dueñas^{1

2}, Andrea Pérez-Arévalo^{1

2}, Xavier Altafaj¹, Sergi Ferré³, Francisco Ciruela^{1

2}

¹ Unitat de Farmacologia, Departament Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
² Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
³ Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, United States.

No abstract available

Keywords: adenosine A1 receptor; early-onset Parkinson's disease; oligomer.